Clinical characteristics and outcome of patients with cirrhosis and refractory ascites

Liver International

Volumn 24, Issue 5, 2004, Pages 457-464

  Moreau, Richard ^a   Delègue, Paul ^a   Pessione, Fabienne ^a   Hillaire, Sophie ^a   Durand, François ^a   Lebrec, Didier ^a   Valla, Dominique Charles ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Alcohol; Chronic liver disease; Diabetes; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

DIURETIC AGENT;

ADULT; AGE; AGED; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROGNOSIS; REFRACTORY ASCITES; RISK ASSESSMENT; SURVIVAL RATE; FOLLOW UP; FRANCE; HOSPITALIZATION; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; RISK;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASCITES; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 16644367872     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0991.x     Document Type: Article

References (20)

1. Runyon B A. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998; 27: 264-72.
2. Moore K P, Wong F, Ginès P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-66.
3. Ginès A, Fernandez-Esparrach G, Monescillo A, Vila C, Doménech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002-10.
4. Arroyo V, Gines P, Gerbes A L, Dudley F J, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164-76.
5. Salerno F, Borroni G, Moser P, Badalamenti S, Cassara L, Maggi A, et al. Survival and prognosis of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993; 38: 514-9.
6. Stanley M M, Ochi S, Lee K K, Nemchausky B A, Greenlee H B, Allen J I, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989; 321: 1632-8.
7. Ginés P, Arroyo V, Vargas B, Planas R, Casafont F, Panés J, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325: 829-35.
8. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis ard refractory ascites. A randomized trial. J Hepatol 1996; 25: 135-44.
9. Rössle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1701-7.
10. Ginès P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath P S, Ruiz Del Arbol L, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839-47.
11. Sanyal A J, Genning C, Reddy K R, Wong F, Kowdley K V, Benner K, et al. The north american study for the treatment of refractory ascites. Gastroenterology 2003; 124: 634-41,
12. Véldt B J, Laine F, Guillygomarc'h A, Lauvin L, Boudjema K, Messner M, et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 2002; 36: 93-8.
13. Gentilini P, Laffi G, La Villa G, Romanelli R G, Blendis L M. Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? J Hepatol 1999; 31: 1088-97.
14. Capone R R, Buhac I, Kohberger R C, Balint J A. Resistant ascites in alcoholic liver cirrhosis. Course and prognosis. Dig Dis Sci 1978; 23: 867-71.
15. D'Amico G, Morabito A, Pagliaro L, Marubini E, and the Liver Study Group of V. Cervello Hospital. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-75.
16. Figueras J J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997; 25: 1485-9.
17. Bruix J, Llovet J M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-24.
18. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20: 119-25.
19. Neuberger J, Schulz K H, Day C, Fleig W, Berlakovich G A, Berenguer M, et al. Transplantation for alcoholic liver disease. J Hepatol 2002; 36: 130-7.
20. Lauer G M, Walker B D. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.